Senores Pharmaceuticals IPO listing

LIVE
Senores Pharmaceuticals Share Price Highlights: Stock ends 6% below listing price but 43% above IPO price
Senores Pharmaceuticals shares listed at 53% premium on NSE and 52% premium on BSE. Following the bumper debut, the stock witnessed some profit taking at higher levels.
Senores Pharmaceuticals IPO listing bonanza: shares debut at 53% premium, pare gains at close
Ahmedabad-based Senores Pharmaceuticals raised Rs 582.11 crore through its IPO, which comprised a fresh issue of Rs 500 crore and an offer-for-sale of Rs 82.11 crore.
Senores Pharmaceuticals Listing: Shares debut strong with 53% premium over IPO price
The issue had opened for public subscription on December 20 to raise about ₹582 crore from the primary market.
Senores Pharmaceuticals Share Price Live: Senores Pharma shares drop 10% post debut; list at 53% premium at Rs 600 over IPO price
Shares of Senores Pharmaceuticals are scheduled to be listed on the stock exchanges today on Monday, December 30, following a great response from investors during the bidding period.
Senores Pharmaceuticals Lists At Premium Of 53% Over IPO Price
The Rs 582.1-crore Senores Pharmaceuticals offering consists of a fresh issue of Rs 500 crore and an offer for sale of Rs 82.1 crore.
Senores Pharmaceuticals IPO makes a healthy debut on the exchange, lists at 53% premium
Shares of Senores Pharmaceuticals Limited made a healthy debut on the exchange to list at a 53.45% premium. The scrip listed Rs 593.70 per share on BSE, a premium of 51.84% and Rs 600 per share on NSE,
Senores Pharmaceuticals' Stellar Stock Market Debut
Senores Pharmaceuticals Ltd witnessed a stellar debut on stock exchanges, with shares surging nearly 43% against the issue price. The Ahmedabad-based company's IPO attracted substantial interest with 93.
Senores Pharmaceuticals share price dips over 6% after strong debut in Indian stock market. Buy, sell or hold?
Senores Pharmaceuticals share price listed on the NSE at ₹600 apiece while it opened on the BSE at ₹593.70 per share mark
Senores Pharmaceuticals Makes Strong Stock Market Debut, Listed At 53% Over Issue Price
Senores Pharmaceuticals saw a strong market reception as its shares debuted with a premium of over 50 per cent on both the NSE and BSE. This positive debut comes after a highly successful IPO, which was subscribed 93 times,
Senores Pharmaceuticals IPO Surges with Over 53% Premium Debut
Senores Pharmaceuticals Ltd had a successful IPO, with shares surging over 53% from the issue price of Rs 391. The company's market valuation hit Rs 2,657.29 crore. The proceeds will aid in expanding manufacturing,
Senores Pharmaceuticals IPO listing: Does GMP suggest strong market debut?
Senores Pharmaceuticals shares are set to make their market debut on Monday after the allotment was finalised on December 26, 2024. Senores Pharmaceuticals IPO got a very strong response during its three-day bidding period from December 20 to December 24.
The Financial Express20h
Senores Pharmaceuticals IPO Vs Ventive Hospitality IPO: Which issue will list with higher gains?
Compare Senores Pharma and Ventive IPOs for potential listing gains. Discover which could deliver better returns!
ET Now on MSN4d
Senores Pharmaceuticals IPO GMP today; allotment status date and time - check online guide, tutorial
Senores Pharmaceuticals IPO subscription status Senores Pharmaceuticals fetched 51.13 times subscriptions on the final day of ...
India Infoline12h
Senores Stock Dips from High, Remains Above IPO Price
Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.